Efficacity of Cognitive Remediation Treatment Compared to a Controlled Group in Young Patient With Anorexia Nervosa (RECOGAMEA)

April 28, 2020 updated by: Assistance Publique - Hôpitaux de Paris

Prospective Evaluation of Neuropsychological and Clinical Impact of Cognitive Remediation Program Among Children and Adolescents Treated for Anorexia Nervosa

The aim of research is to test in a randomized clinical trial with active sessions, the efficacy of cognitive remediation therapy in children anorexia nervosa compared to a controlled group. The investigators want to confirm the efficacy of cognitive remediation treatment in children's flexibility problems.

Study Overview

Detailed Description

In this research, the investigators want to evaluate remediation cognitive therapy in anorexia nervosa compared to a controlled group (relaxation) based on different factors that testified the cognitive improvement of patients: one week after therapy, six months after and one year after.

Those factors are:

Weight, perfectionism and food symptomatology, temperament, therapeutic alliance and change motivation, clinical evolution of anorexia nervosa, self esteem, executive functions, neuropsychological performance (flexibility and central coherence).

Study Type

Interventional

Enrollment (Actual)

65

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75019
        • Asch

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 16 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Pathology

    • DSM IV criteria of restrictive anorexia nervosa (AN- R), but not requiring amenorrhea or DSM V
    • Accepting and their parents to participate in the study ( signed consents )
  • Topics

    • Female supported for AN- R
    • Aged 8 to 16 years
    • Fluent French
    • Inpatients or outpatients suffering of restrictive anorexia nervosa
  • Treatments

    • Supports standard load ( family psychotherapy , dietary management , medical monitoring )
    • In case of anxiety or depression , patients may receive additional psychotropic prescription which should be mentioned in the record
    • Treatments previously followed by patients and treatments for other conditions should be described

Exclusion Criteria:

  • Pathology

    • Mental Retardation
    • Schizophrenia
    • Organic brain disorder ( encephalitis , degenerative brain tumor , cerebral neuro- degenerative disease , multiple sclerosis , amyotrophic lateral sclerosis, epilepsy )
    • Metabolic Pathology interfere with feeding or its regulation
    • Trouble consumption current substance
    • Severe somatic pathology , progressive or likely to be life -threatening
  • Topics The subjects are not mastering the French language will not be considered

    • Subjects or parents do not have sufficient capacity for understanding instructions and consent
    • No affiliation in social security ( beneficiary or legal )

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cognitive remediation therapy
10 sessions of the cognitive remediation therapy program conducted during five weeks

Our scheme comprises 10 biweekly sessions ( 5 in group and 5 single) . Each session last about 45 minutes.

Individual sessions will be held with the patient and a therapist trained in the CRT; group sessions will be led by two therapists trained in CRT and regroup the maximum 5 patients.

Placebo Comparator: relaxation therapy
10 relaxation sessions during 5 weeks
Our scheme comprises 10 biweekly sessions. Each session last about 45 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
cognitive flexibility
Time Frame: 6 months after therapy
behavioral characteristics related to cognitive difficulties flexibility of anorexic patients, as measured in the medium term (6 months post treatment) by the score of the subscale "shift" BRIEF parent version of the scale (BRIEF-PR).
6 months after therapy

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight status
Time Frame: 6 months and one year
Assess the impact of cognitive remediation therapy on :Weight status by the Body Mass Index
6 months and one year
Food symptoms and perfectionism
Time Frame: 6 months and one year
Assess the impact of cognitive remediation therapy on :Food symptoms and perfectionism measured by the Eating Disorders Inventory auto questionnaire, EDI-2
6 months and one year
Temperamental profile
Time Frame: 6 months after therapy
Assess the impact of cognitive remediation therapy on :Temperamental profile measured by the Junior Temperament and Character Inventory questionnaire
6 months after therapy
Therapeutic alliance and motivation to change
Time Frame: 6 months and one year
Assess the impact of cognitive remediation therapy on : therapeutic alliance and motivation to change measured by self-reported scales Helping Alliance Questionnaire-11 and MOTIV
6 months and one year
Self-esteem
Time Frame: 6 months and one year
measured by the Rosenberg Self-Esteem Scale
6 months and one year
Executive functions
Time Frame: 6 months and one year
measured by the scale BRIEF-Parent Report
6 months and one year
Neuropsychological performance in particular flexibility and central coherence
Time Frame: 6 months and one year
measured by tests of WCST (Wisconsin Card Sorting Test), Geft (Group Embedded Figure Test) and tests the battery Ravello Profile (Tower, Verbal Fluency Test VFT, Trail Making Test TMT, Rey Complex Figure Test Osterreich ROCFT )
6 months and one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Asch Muriel, PHD, -Hôpital Robert Debré, Service de psychiatrie de l'enfant et de l'adolescent

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2015

Primary Completion (Actual)

December 22, 2019

Study Completion (Actual)

December 22, 2019

Study Registration Dates

First Submitted

January 27, 2015

First Submitted That Met QC Criteria

March 23, 2015

First Posted (Estimate)

March 27, 2015

Study Record Updates

Last Update Posted (Actual)

April 29, 2020

Last Update Submitted That Met QC Criteria

April 28, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anorexia Nervosa

Clinical Trials on Cognitive remediation therapy

Subscribe